危重症患者临床试验中替代决策者提供知情同意的障碍与促进因素:一项定性研究
该定性研究对20名接受机械通气的危重症患者的替代决策者进行半结构化访谈,录音并逐字转录,采用归纳法进行主题分析。分析确认了对系统的信任、评估试验风险与获益、帮助他人的愿望和构建医学知识是试验入组的重要动机因素。识别出两个既往未描述的担忧:可能干扰临床治疗决策以及对安慰剂的负面情绪。替代决策者认为公共表彰和参与慈善捐赠是有利的潜在干预措施,但对直接经济激励和在医疗查房时优先考虑研究参与者持负面看法。作者认为未来需要研究评估以患者名义慈善捐赠和公共表彰是否是促进危重症试验入组的有效策略。
要点
- 对20名机械通气危重症患者的替代决策者访谈发现,对系统的信任、评估风险获益、利他愿望和构建医学知识是入组的重要动机因素。
- 两个既往未描述的担忧:试验可能干扰临床治疗决策,以及对安慰剂的负面情绪。
- 替代决策者将公共表彰和慈善捐赠视为鼓励入组的有利潜在干预措施。
- 替代决策者对直接经济激励和在医疗查房时优先考虑研究参与者持负面看法。
- 作者认为未来需要研究评估以患者名义慈善捐赠和公共表彰是否是促进危重症试验入组的有效策略。
适用人群与场景
- 20名接受机械通气的危重症患者的替代决策者。
研究设计与关键结果
- 研究类型为定性研究,对20名替代决策者进行半结构化访谈,录音并逐字转录,采用归纳法进行主题分析。
- 主题分析确认对系统的信任、评估试验风险与获益、帮助他人的愿望和构建医学知识是试验入组的重要动机因素。
- 识别出两个既往未描述的担忧:可能干扰临床治疗决策以及对安慰剂的负面情绪。
- 替代决策者认为公共表彰和参与慈善捐赠是有利的潜在干预措施。
- 替代决策者对直接经济激励和在医疗查房时优先考虑研究参与者持负面看法。
证据类型、等级与局限
- 证据类型:定性研究(半结构化访谈)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为未来需要研究评估以患者名义慈善捐赠和公共表彰是否是促进危重症试验入组的有效策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Enrollment into critical care clinical trials is often hampered by the need to rely on surrogate decision-makers. To identify potential interventions facilitating enrollment into critical care clinical trials, a better understanding of surrogate decision-making for critical care clinical trial enrollment is needed.
RESEARCH QUESTION: What are the barriers and facilitators of critical care trial enrollment? What are surrogate decision-makers' perspectives on proposed interventions to facilitate trial enrollment?
STUDY DESIGN AND METHODS: We conducted semistructured interviews with 20 surrogate decision-makers of critically ill patients receiving mechanical ventilation. The interviews were recorded and transcribed verbatim, and analyzed for themes using an inductive approach.
RESULTS: Thematic analysis confirmed previous research showing that trust in the system, assessing the risks and benefits of trial participation, the desire to help others, and building medical knowledge as important motivating factors for trial enrollment. Two previously undescribed concerns among surrogate decision-makers of critically ill patients were identified, including the potential to interfere with clinical treatment decisions and negative sentiment about placebos. Surrogates viewed public recognition and charitable donations for participation as favorable potential interventions to encourage trial enrollment. However, participants viewed direct financial incentives and prioritizing research participants during medical rounds negatively.
INTERPRETATION: This study confirms and extends previous findings that health system trust, study risks and benefits, altruism, knowledge generation, interference with clinical care, and placebos are key concerns and barriers for surrogate decision-makers to enroll patients in critical care trials. Future studies are needed to evaluate if charitable giving on the patient's behalf and public recognition are effective strategies to promote enrollment into critical care trials.
参考来源
- Krutsinger DC, Maloney SI, Courtright KR, et al. Barriers and Facilitators of Surrogates Providing Consent for Critically Ill Patients in Clinical Trials: A Qualitative Study. Chest. 2024. PMID: 38387647. doi:10.1016/j.chest.2024.02.027
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。